ECM Weekly (27th June 2021) - Didi, Xpeng, Zylox, Dingdong, EBeauty, Chaoju Eye Care, Keymed Bio
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
399 Views
Keymed (康诺亚生物) IPO: A Free Option for Overseas Potential
Keymed's IPO valuation only reflects the value derived from China market. The value derived from the overseas market will be the free option for...
513 Views
Keymed (康诺亚生物) Pre-IPO: Differentiated Products but Far from Commercialization
We highlight that Keymed is led by experienced management team with strong R&D track record which is evidenced by its differentiated product pipeline.
345 Views
Pre-IPO Keymed Biosciences - Challenges Are Inevitable Despite Some Advantages on Pipeline
This article analyzed Keymed Biosciences in terms of the insights on core product CM310 and two key products CM326 and CMG901, the advantages, the...
715 Views